Dana-Farber Cancer Institute, Boston, MA.
Weill Cornell Medicine, Sandra and Edward Meyer Cancer Center, New York, NY.
Clin Breast Cancer. 2023 Oct;23(7):746-751.e1. doi: 10.1016/j.clbc.2023.07.009. Epub 2023 Aug 8.
Young women treated for breast cancer experience unique concerns in follow-up. We developed a program to direct young breast cancer survivors to a dedicated survivorship visit and evaluated their experience.
Early-stage breast cancer patients diagnosed under age 45 within 1 year of completing breast surgery, chemotherapy and/or radiation therapy were systematically referred for a survivorship visit. Patients completed a one-time, post-visit survey about their experience.
Sixty-nine out of 89 (78%) eligible patients attended a survivorship visit, and 40 of those 69 (58%) completed the post-visit survey. Most respondents learned about the survivorship clinic after completing treatment (30/40; 75%) and reported the survivorship visit occurred at an appropriate time in their follow-up care (26/40; 65%). Of the 34 respondents who reported receiving a treatment summary and survivorship care plan, 30 indicated it would be helpful when visiting their primary care provider (88.2%). Participants reported gaining valuable knowledge about cancer treatment (28/38; 73.7%), side effects (32/39; 82.1%), and cancer surveillance (30/40; 75%), and discussed emotional health (32/40; 80%), exercise (38/40; 95%), and ongoing cancer surveillance (32/37; 86.5%). Several reported intentions to make changes to their follow-up oncology care (8/20; 40%), exercise routines (16/30; 53.3%), and emotional health care (15/22; 68.2%).
Survivorship visit navigation is feasible for young breast cancer patients. These visits can influence knowledge gained and intended future health plans and behaviors. Systematic approaches to survivorship care may improve the physical and mental health of cancer survivors. Future health care delivery research focused on survivorship is warranted.
接受乳腺癌治疗的年轻女性在随访中会遇到独特的问题。我们开发了一个项目，将年轻的乳腺癌幸存者引导至专门的生存随访，并评估了他们的体验。
在完成乳房手术、化疗和/或放疗后 1 年内被诊断为早期乳腺癌且年龄在 45 岁以下的患者被系统地推荐进行生存随访。患者在随访后完成一次性的调查，以了解他们的体验。
在 89 名符合条件的患者中，有 69 名（78%）参加了生存随访，其中 40 名（58%）完成了随访后的调查。大多数受访者在完成治疗后（30/40；75%）了解到生存诊所，并报告说在随访护理中进行生存随访的时间恰到好处（26/40；65%）。在 34 名报告收到治疗总结和生存护理计划的受访者中，有 30 名表示在就诊时会有所帮助（88.2%）。参与者报告说，他们从随访中学到了关于癌症治疗（28/38；73.7%）、副作用（32/39；82.1%）和癌症监测（30/40；75%）的宝贵知识，并讨论了他们的心理健康（32/40；80%）、锻炼（38/40；95%）和持续的癌症监测（32/37；86.5%）。一些人表示打算对他们的后续肿瘤学治疗（8/20；40%）、锻炼习惯（16/30；53.3%）和心理健康护理（15/22；68.2%）进行更改。
生存随访导航对年轻的乳腺癌患者是可行的。这些随访可以影响患者的知识获取以及未来的健康计划和行为。系统的生存护理方法可能会改善癌症幸存者的身心健康。未来有必要进行以生存为重点的医疗保健提供研究。
